Description
Recent breakthroughs in science and technology have led to a concomitant growth in exploratory studies into the definitive properties of traditional therapies employed in medicine and pharmacology. Complementary and alternative medicine (CAM) involves a diverse range of medicinal and health practices and products that are typically not part of conventional medicine. Presently, there are a multitude of research studies investigating the promise and potential of CAM products in disease therapy. A record of concentric investigations into the therapeutic properties of products may assure researchers and the public of safety, efficacy, and beneficent implications. While big pharma and the biotech industry race to produce vaccines and effective and efficient drugs, especially in the times of a pandemic, it is an excellent opportunity to discuss complementary and alternative medicinal products. Research investigations continue to exhibit the enormous possibilities of CAM and the financial benefits thereof.
Exploring Complementary and Alternative Medicinal Products in Disease Therapy is an innovative reference book that presents a holistic overview and makes an intelligent argument for an aggressive, sustained research into the capabilities of CAM in disease therapy applications. The chapters are a compendium of recent results of CAM in areas such as topical pre-clinical and clinical trial studies undertaking this effort. They demonstrate one or more instances where a continuum of research findings on certain CAM products are indicative of the potential CAM has in the treatment of a plethora of diseases and comorbidities. This book is a valuable reference tool for pharmaceutical companies, healthcare providers, professionals and practitioners, epidemiologists, researchers, academicians, and students interested in the safety, efficiency, beneficence, and cost implications of employing CAM in patient care.
Author's/Editor's Biography
Etetor Eshiet (Ed.)
Etetor Roland Eshiet, Sr., is a graduate of Texas Tech University’s, The Institute of Environmental and Human Health (TIEHH) and the Department of Environmental Toxicology, doctoral program, Lubbock, Texas, USA. He possesses a Bachelor of Science (Hons) degree in Applied Chemistry, and a Masters’ degree in Petroleum Chemistry & Petrochemicals. He has obtained certifications, with distinction, in Data Management for Clinical Research (DMCR), Design and Interpretation of Clinical Trials (DICT), and Drug Discovery from the Department of Biomedical Informatics, Vanderbilt University; Bloomberg School of Public Health, John Hopkins University; and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, respectively. Dr. Eshiet is Managing Consultant at Sustainable Energy Environmental and Educational Development (SEEED), and Co-Founder of Sustainable Development Group, Incorporated (SDGi), USA. His area of immediate and particular interest and experience include pharmacovigilance, biotechnology, drug discovery and development processes, and the continuum of explorative and investigative research that culminates in the synthesis, production and commercialization of drug products and substrates effective and beneficent in the prevention, management and treatment of a panoply of diseases and comorbidities.
Dr. Eshiet has publications in reputable journals and books, and serves on the editorial board of a number of journals. He is the author of a book entitled, “Complementary and Alternative Medicine’s Place in Modern Medicine: A Spotlight on Brickellia cavanillesii (Asteraceae).”